BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/27/2018 7:22:43 AM | Browse: 1324 | Download: 2343
 |
Received |
|
2018-05-31 01:17 |
|
Peer-Review Started |
|
2018-05-31 02:58 |
|
First Decision by Editorial Office Director |
|
2018-06-20 23:00 |
|
Return for Revision |
|
2018-07-04 08:31 |
|
Revised |
|
2018-07-06 01:33 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2018-07-13 08:35 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2018-07-16 01:38 |
|
Articles in Press |
|
2018-07-16 01:38 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-08-27 01:40 |
|
Publish the Manuscript Online |
|
2018-08-27 07:22 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Amporn Atsawarungruangkit, Jirat Chenbhanich and George Dickstein |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Amporn Atsawarungruangkit, BPharm, MD, Doctor, Doctor, Research Fellow, Department of Medicine, MetroWest Medical Center, 115 Lincoln St., Framingham, MA 01702, United States. a.atsawarungruangkit@mwmc.com |
| Key Words |
Insulin resistance; Fatty liver; Hepatosteatosis; Metabolic syndrome; C-peptide |
| Core Tip |
Non-alcoholic fatty liver disease (NAFLD) is a growing global epidemic and associated with many conditions and factors, including insulin resistance. However, C-peptide has not been used in practice to assess insulin resistance in NAFLD patients. Using a large national dataset, we demonstrated that three most important risk factors for NAFLD are waist circumference, fasting C-peptide, and alanine aminotransferase, respectively. Such results revealed that C-peptide superior to measurement of fasting insulin levels and can potentially be used for screening or monitoring the degree of insulin resistance in NAFLD. |
| Publish Date |
2018-08-27 07:22 |
| Citation |
Atsawarungruangkit A, Chenbhanich J, Dickstein G. C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population. World J Gastroenterol 2018; 24(32): 3663-3670 |
| URL |
http://www.wjgnet.com/1007-9327/full/v24/i32/3663.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v24.i32.3663 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
